Location History:
- Homestead, FL (US) (2012)
- Marshfield, MA (US) (2011 - 2024)
Company Filing History:
15 out of 22 
1 out of 832,843 Years Active: 2011-2024
Title: Exploring the Innovations of Inventor Daniel S. Rivera
Introduction
Daniel S. Rivera, a prolific inventor based in Marshfield, MA, has made significant contributions to the field of biotechnology, particularly in the development of regulatory T cell epitopes. With an impressive portfolio of 15 patents, he is renowned for his innovative work that has potential applications in immunology and therapeutic methods.
Latest Patents
Among his recent patents, one of the notable inventions is titled "Regulatory T cell epitopes, compositions and uses thereof." This invention is directed towards T cell epitopes, comprising a peptide or polypeptide chain that includes at least a portion of an immunoglobulin constant or variable region. Furthermore, the invention elaborates on various methods for utilizing and creating these epitopes, emphasizing their importance in advancing medical therapies.
Career Highlights
Daniel is currently affiliated with Epivax, Inc., a company focused on immunological innovations. His expertise and dedication to research and development have significantly enhanced the capabilities and potential of immune-based therapies in the biotech industry. His impressive record of patent filings attests to his commitment to advancing scientific knowledge and practical applications.
Collaborations
Throughout his career, Daniel has collaborated with esteemed colleagues, including Anne Searls De Groot and William Martin. These partnerships foster an innovative environment that enhances the development of groundbreaking solutions in the field of immunology. Together, they contribute to a collaborative effort that exemplifies the synergy within research institutions and companies alike.
Conclusion
Daniel S. Rivera stands out as an influential figure in the realm of biotechnology thanks to his extensive patent portfolio and commitment to innovation. His work at Epivax, Inc. reflects a dedication to improving health outcomes through scientific exploration. The inventions and collaborations he has engaged in are paving the way for advancements that may revolutionize treatment methodologies in immunology and beyond.